Neonates are a particularly sensitive group due to their developing organs and unique physiology. Standard dosing regimens used in adults or older children may not be appropriate. Adaptive dose finding designs enable researchers to tailor dosages specifically for neonates, minimizing the risk of adverse effects while maximizing therapeutic benefits. This approach is essential for conditions such as neonatal sepsis, respiratory distress syndrome, and neonatal jaundice.
